Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase L1

Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase L1

US Patent 11016092 · Granted May 25, 2021

Estimated economic value: $134,850,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in2024
Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in2024
Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in2024
Methods for aiding in the diagnosis and determination of the extent of traumatic2024
Methods for aiding in the diagnosis and determination of the extent of traumatic2024
Methods for aiding in the diagnosis and determination of the extent of traumatic2024
Methods for aiding in the diagnosis and determination of the extent of traumatic2024
Methods for measuring ubiquitin carboxy—terminal hydrolase L1 levels in blood2024
Methods for aiding in the diagnosis and evaluation of a subject who has sustaine2024
Methods for aiding in the diagnosis and evaluation of a subject who has sustaine2024
Methods for aiding in diagnosing and evaluating a traumatic brain injury in a hu2024
Methods for aiding in diagnosing and evaluating a traumatic brain injury in a hu2024